A major discovery in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in many forms of malignancies, leading https://bookmark-dofollow.com/story29825779/nanobodies-reactivate-tumor-suppressor-p53-new-promising-hope-for-malignant-treatment